Dermal ISF microsampling is a transformative technology in the skincare and cosmetics industry, Enabling non-invasive access to biomarkers that offer valuable insights into skin health and highly personalized products.
A painless, self-administrable sampling method can improve inclusion and compliance for studies, streamlining drug development and decentralized trials. Its ability to support longitudinal sampling enhances pharmacokinetics, dosing optimization, and precision medicine.
Microsampling enables minimally invasive, high-frequency sample collection, providing rich data for biomarker discovery and multi-omics research. By integrating with bioinformatics, it enhances disease modeling, accelerates drug target identification, and deepens our understanding of common diseases.
By improving accessibility and easy-of-use, microsampling supports epidemiological research, targeted interventions and data-driven public health strategies — providing more effective prevention and management of chronic diseases and global epidemics.
Our proprietary product technology is a result of +5 years of sear by our world-leading team in microsampling at the Swedish Royal Institute of Technology (KTH).
Strategic partnerships is the foundation of our business model, together we can unlock the full potential of your bio-information needs.
We currently focus on providing research customers with a robust, user-friendly and price-competitive microsampling platform for collecting body fluids from the skin.
Consumers increasingly seek products tailored to their unique skin profiles. ISF facilitates this through PROXIMAL biomarker data.
Clinical trials face significant challenges monitoring drug efficacy and adverse events, often due to resource-intensive processes and limitations in continuous data collection.
Easy access to bio-information facilitates discoveries in genomics, proteomics, and systems biology, accelerating advancements in health and disease understanding.
microsampling in rural and developing regions can enhance healthcare accessibility And reduce logistical cost burdens.
decentralized sampling help drive the shift from reactive to proactive care, reducing hospital visits and lowering healthcare costs.
At home self-sampling enables population-scale screening, enhancing precision in epidemiology and more effective interventions,
Microsampling can help users track biomarkers for disease management, nutrition, fitness, and mental well-being.
Collecting smaller sample volumes minimizes discomfort, sedation and
Decreases the need for additional animals in studies,
